middle.news
Why Did Botanix Shares Drop? Inside the US Drug Pricing Rumor
2:44am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Why Did Botanix Shares Drop? Inside the US Drug Pricing Rumor
2:44am on Monday 2nd of June, 2025 AEST
Key Points
No undisclosed price-sensitive information affecting Botanix
Price volatility linked to rumored US executive order on pharmaceutical pricing
Sofdra approved only in the US; Ecclock marketed in Japan with different formulation
Botanix does not expect proposed US order to impact its pricing outside the US
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Botanix Pharmaceuticals (ASX:BOT)
OPEN ARTICLE